Juneau Biosciences

Juneau Biosciences is a privately held medical genetics company based in Salt Lake City, Utah. Founded in 2007, the firm employs 15 people and generates $5 million in annual revenue. The company focuses on developing innovative diagnostic products for diseases that primarily affect women. Their current research centers on endometriosis, a condition affecting an estimated 10% of women of reproductive age, with the aim of developing novel molecular diagnostics and therapeutics for this condition. Juneau Biosciences plans to expand its research to include preterm labor and other gynecological and obstetric disorders in the coming years. Juneau Biosciences distinguishes itself through its knowledgeable team, state-of-the-art facilities, and innovative research techniques. The company also seeks to form strategic alliances with healthcare partners to commercialize its novel discoveries. For more information about Juneau Biosciences and its groundbreaking research, visit juneaubiosciences.com.